A Study to Investigate Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type Psoriasis

Psoriatic Plaque Clinical Trial

Official title:
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type Psoriasis

Status Active, not recruiting

Clinical Trial Summary

The study is designed to investigate efficacy and safety of KBL697 in patients with Moderate Plaque Type Psoriasis. KBL697 has been developed as a potential new treatment for Psoriatic Plaque.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04911751
Study type	Interventional
Source	KoBioLabs
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	November 8, 2021
Completion date	March 26, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05144165` - Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
Recruiting	`NCT02999776` - Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis	Phase 1
Recruiting	`NCT04099979` - A Pilot Study to Explore the Role of Gut Flora in Psoriasis
Completed	`NCT03726489` - Light Treatment Effectiveness (LITE) Study	N/A
Completed	`NCT03630939` - A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis	Phase 1/Phase 2